Results 231 to 240 of about 1,116,011 (264)
Some of the next articles are maybe not open access.
Pathology of coronary atherosclerosis
Progress in Cardiovascular Diseases, 1971Abstract Histologic examination of coronary arteries reveals many features of pertinence. In infants, a new layer, the musculo-elastic layer, develops focally associated with thickening of the intima. Later in life, distinction of this normal process from pathologic states may be difficult. In cross sections, two types of lesions are seen: one purely
Jesse E. Edwards, Zeev Vlodaver
openaire +3 more sources
Journal of the American Medical Association (JAMA), 2004
CONTEXT Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and mortality. However, the optimal strategy and target level for lipid reduction remain uncertain.
S. Nissen +11 more
semanticscholar +1 more source
CONTEXT Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and mortality. However, the optimal strategy and target level for lipid reduction remain uncertain.
S. Nissen +11 more
semanticscholar +1 more source
Dehydroepiandrosterone and Coronary Atherosclerosis
Annals of the New York Academy of Sciences, 1995Tissue culture, animal model, and epidemiologic studies suggest that dehydroepiandrosterone (DEHA) may inhibit atherosclerosis through its potent antiproliferative effects. To examine the relation between DHEA and a direct measure of coronary atherosclerosis, plasma DHEA, and DHEA sulfate (DHEAS) levels were determined in 206 middle-aged patients ...
openaire +3 more sources
Progression of Coronary Atherosclerosis
New England Journal of Medicine, 1984Time, the severity of preexisting arterial stenosis, and coronary-artery surgery affect the progression of coronary atherosclerosis. As plaque formation worsens, the probability of acute obstruction increases significantly in medical and surgical patients.1 No clinical or laboratory risk factors consistently predict coronary arterial progression.
openaire +3 more sources
Coronary Atherosclerosis and Interventional Cardiology [PDF]
Archives of Medical Research, 2015 The atherosclerotic process in coronary arteries begins with endothelial dysfunction and may provoke thrombotic total occlusion and myocardial infarction. In this state-of-the-art review, we discuss recent evidence of atheroslerosis, vulnerable plaque, and hemodynamic changes in the coronary tree, as well as the current techniques we implement in the ...
Manuel Ben Adoniram Gaxiola-Macías +3 more
openaire +2 more sources
Regression of Coronary Atherosclerosis
New England Journal of Medicine, 1990The study of therapeutic interventions to bring about the regression of atherosclerosis has been a major part of atherosclerosis research. Until recently, however, this objective had been realized only in experimental animal models. In the early part of this century, Anitschkow1 first demonstrated in a rabbit model of diet-induced atherosclerosis that ...
openaire +2 more sources
Pathogenesis of Coronary Atherosclerosis
1984In the United States between 1974 and 1977, 52% of all causes of death were attributed to cardiovascular diseases {l}. By 1981 and 1982 this figure declined slightly to 49%. Since 1974 ischemic heart diseases have accounted for approximately 65% of all cardiovascular diseases and were responsible for every third death in the United States during this ...
S. David Gertz, Adi Kurgan
openaire +2 more sources
l-Arginine in coronary atherosclerosis
International Journal of Cardiology, 2000Nitric oxide is formed from the N-guanido terminal of the amino acid L-arginine and from molecular oxygen by nitric oxide synthase enzymes. L-arginine administration improves the coronary blood flow response to acetylcholine in patients with normal coronary arteries and hypercholesterolemia, reverses the defective endothelium-dependent vasodilation ...
Tentolouris, C +5 more
openaire +3 more sources
DIET IN CORONARY ATHEROSCLEROSIS
Journal of the American Medical Association, 1960The nutritional approach to the treatment of atherosclerosis was tested in 100 patients with proved coronary atherosclerosis. Fifty patients were treated with a low-fat, low-cholesterol diet. The other 50 patients were not given any specific treatment and acted as controls.
openaire +2 more sources
The Role of Endothelin in Coronary Atherosclerosis
Mayo Clinic Proceedings, 1996During the evolution of coronary atherosclerosis, growth factors, cytokines, and other molecules are involved in cell recruitment, migration, and proliferation. Endothelin is an endothelial-derived vasoconstrictor peptide that possesses mitogenic properties.
Verghese Mathew +2 more
openaire +3 more sources